Mahase, E. (2019). Esketamine is approved in Europe for treating resistant major depressive disorder., 10.1136/bmj.l7069
Link to full text
get the latest
The OPEN Minded Newsletter keeps you informed about the latest psychedelic research & news, articles, exclusive events, job opportunities, programmes, and free resources!
By clicking SUBSCRIBE, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.
